Neurogenetics, the science that studies the genetic basis of the development and function of the nervous system, is a discipline of recent development in Peru, an emerging Latin American country. Herein, we review the clinical, scientific and ethical aspects regarding the development of this discipline, starting with the first molecular diagnosis of neurogenetic diseases, to family and population-based genetic association studies. Neurogenetics in Peru aims to better explain the epidemiology of monogenic and complex neurodegenerative disorders that will help in implementing public health policies for these disorders. The characterization of Peru and its health system, legal issues regarding rare diseases and the historical milestones in neurogenetics are also discussed.
Bibliographical noteFunding Information:
This review was scientifically supported by NIH Research Training Grant No R25 TW009345, funded by the Fogarty International Center, the National Institute of Mental Health, and the NIH Office of the Director Office of Research on Women’s Health and the Office of AIDS Research.
© 2015, Springer-Verlag Berlin Heidelberg.
- Public policies